The adaptations of a client with complete heart block would most likely include:

History

Third-degree atrioventricular (AV) block (complete heart block) has a wide range of clinical presentations. Occasionally, patients are asymptomatic or have only minimal symptoms related to hypoperfusion. In these situations, symptoms include the following:

  • Fatigue

  • Dizziness

  • Impaired exercise tolerance

  • Chest pain

Patients with narrow complex escape rhythms (eg, those whose escape rhythm occurs above the His bundle) are more likely to have minimal symptoms.

More commonly, however, patients are profoundly symptomatic, especially if a wide-complex escape rhythm is present, indicating that the origin of the pacemaker is below the His bundle. In such cases, symptoms can include the following:

  • Syncope

  • Confusion

  • Dyspnea

  • Severe chest pain

  • Sudden death

Because an acute myocardial infarction (MI) can cause complete heart block, patients who concurrently experience an MI can have associated symptoms from the MI, including chest pain, dyspnea, nausea or vomiting, and diaphoresis. Third-degree AV block may be an underlying condition in patients who present with sudden cardiac death.

Patients who have a history of cardiac disease may be on medications that affect the conduction system through the AV node (AVN), including the following:

  • Beta-blockers

  • Calcium channel blockers

  • Digitalis cardioglycosides

The patient’s history of cardiac interventions should be carefully investigated; aortic valve surgery, septal alcohol ablation, proximal anterior descending artery stenting (complicated by compromised flow in the first septal perforator branch), and ablation of the slow or fast pathway of the AVN all may result in third-degree AV block.

The adaptations of a client with complete heart block would most likely include:

Physical Examination

Initial triage of patients with third-degree atrioventricular (AV) block (complete heart block) consists of determining symptoms, assessing vital signs, and looking for evidence of compromised peripheral perfusion. In particular, the physical examination findings of patients with third-degree AV block will be notable for bradycardia, which can be severe.

Careful examination of the neck veins can often show evidence of cannon ‘a’ waves. A variable intensity S1 may be heard on auscultation. In addition, the pulse rate may be slow. If the slow rate or loss of atrial contraction prior to ventricular contraction has caused heart failure, then venous pressures will be elevated, including the jugular venous pressure.

Any new murmurs or gallops should be noted, because strong associations exist between cardiomyopathies, mitral calcification, aortic calcification, or endocarditis and complete AV block. If heart failure is present as evidenced by rales, an S3 gallop, peripheral edema, or hepatomegaly, then a more compelling need for immediate pacing exists.

Because endocarditis, rheumatic fever, and Lyme disease cause heart block, pay attention to any signs of infection or skin rashes during the general examination. This is particularly true in endemic areas for Lyme disease.

Neurologic examination may provide clues to the etiology of AV block because neuromuscular disease, especially myotonic dystrophy and Duchenne muscular dystrophy, can cause AV block.

Signs of congestive heart failure as a result of decreased cardiac output may be present and may include the following:

  • Tachypnea or respiratory distress

  • Rales

  • Jugular venous distention

Patients may have signs of hypoperfusion, including the following:

  • Altered mental status

  • Hypotension

  • Lethargy

In patients with concomitant myocardial ischemia or myocardial infarction (MI), corresponding signs such as the following may be evident on examination:

  • Signs of anxiety (eg, agitation, unease)

  • Diaphoresis

  • Pale or pasty complexion

  • Tachypnea

Regularized atrial fibrillation is the classic sign of complete heart block due to digitalis toxicity. This rhythm occurs because of the junctional escape rhythm.

  1. Narula OS, Scherlag BJ, Javier RP, Hildner FJ, Samet P. Analysis of the A-V conduction defect in complete heart block utilizing His bundle electrograms. Circulation. 1970 Mar. 41(3):437-48. [QxMD MEDLINE Link]. [Full Text].

  2. Kashou AH, Goyal A, Nguyen T, Chhabra L. Atrioventricular block. StatPearls [Internet]. 2022 Jan. [QxMD MEDLINE Link]. [Full Text].

  3. Rosen KM, Dhingra RC, Loeb HS, Rahimtoola SH. Chronic heart block in adults. Clinical and electrophysiological observations. Arch Intern Med. 1973 May. 131(5):663-72. [QxMD MEDLINE Link].

  4. Costedoat-Chalumeau N, Georgin-Lavialle S, Amoura Z, Piette JC. Anti-SSA/Ro and anti-SSB/La antibody-mediated congenital heart block. Lupus. 2005. 14(9):660-4. [QxMD MEDLINE Link].

  5. Steinberg L. Congenital heart block. Card Electrophysiol Clin. 2021 Dec. 13(4):691-702. [QxMD MEDLINE Link].

  6. Simmons MA, Rollinson N, Fishberger S, Qin L, Fahey J, Elder RW. Modern incidence of complete heart block in patients with L-looped ventricles: does univentricular status matter?. Congenit Heart Dis. 2015 Sep-Oct. 10(5):E237-42. [QxMD MEDLINE Link].

  7. Finsterer J, Stollberger C, Steger C, Cozzarini W. Complete heart block associated with noncompaction, nail-patella syndrome, and mitochondrial myopathy. J Electrocardiol. 2007 Oct. 40(4):352-4. [QxMD MEDLINE Link].

  8. Bestetti RB, Cury PM, Theodoropoulos TA, Villafanha D. Trypanosoma cruzi myocardial infection reactivation presenting as complete atrioventricular block in a Chagas' heart transplant recipient. Cardiovasc Pathol. 2004 Nov-Dec. 13(6):323-6. [QxMD MEDLINE Link].

  9. Ma TS, Collins TC, Habib G, Bredikis A, Carabello BA. Herpes zoster and its cardiovascular complications in the elderly--another look at a dormant virus. Cardiology. 2007. 107(1):63-7. [QxMD MEDLINE Link].

  10. Abuin G, Nieponice A, Barcelo A, Rojas-Granados A, Leu PH, Arteaga-Martinez M. Anatomical reasons for the discrepancies in atrioventricular block after inferior myocardial infarction with and without right ventricular involvement. Tex Heart Inst J. 2009. 36(1):8-11. [QxMD MEDLINE Link]. [Full Text].

  11. Nguyen HL, Lessard D, Spencer FA, et al. Thirty-year trends (1975-2005) in the magnitude and hospital death rates associated with complete heart block in patients with acute myocardial infarction: a population-based perspective. Am Heart J. 2008 Aug. 156(2):227-33. [QxMD MEDLINE Link]. [Full Text].

  12. Aguiar Rosa S, Timoteo AT, Ferreira L, et al. Complete atrioventricular block in acute coronary syndrome: prevalence, characterisation and implication on outcome. Eur Heart J Acute Cardiovasc Care. 2018 Apr. 7(3):218-23. [QxMD MEDLINE Link].

  13. Merin O, Ilan M, Oren A, et al. Permanent pacemaker implantation following cardiac surgery: indications and long-term follow-up. Pacing Clin Electrophysiol. 2009 Jan. 32(1):7-12. [QxMD MEDLINE Link].

  14. Garcia RU, Safa R, Karpawich PP. Postoperative complete heart block among congenital heart disease patients: contributing risk factors, therapies and long-term sequelae in the current era. Progr Pediatr Cardiol. June 2018. 49:66-70.

  15. Bjerre Thygesen J, Loh PH, Cholteesupachai J, Franzen O, Sondergaard L. Reevaluation of the indications for permanent pacemaker implantation after transcatheter aortic valve implantation. J Invasive Cardiol. 2014 Feb. 26(2):94-9. [QxMD MEDLINE Link].

  16. Urena M, Webb JG, Tamburino C, et al. Permanent pacemaker implantation after transcatheter aortic valve implantation: impact on late clinical outcomes and left ventricular function. Circulation. 2014 Mar 18. 129 (11):1233-43. [QxMD MEDLINE Link]. [Full Text].

  17. Nazif TM, Dizon JM, Hahn RT, et al, for the PARTNER Publications Office. Predictors and clinical outcomes of permanent pacemaker implantation after transcatheter aortic valve replacement: the PARTNER (Placement of AoRtic TraNscathetER Valves) trial and registry. JACC Cardiovasc Interv. 2015 Jan. 8(1 Pt A):60-9. [QxMD MEDLINE Link]. [Full Text].

  18. Gill R, Meghrajani V, Ali S, Riasat M. Delayed onset atrioventricular block after surgical aortic valve replacement: a rare entity. Cureus. 2022 Jun. 14(6):e25606. [QxMD MEDLINE Link]. [Full Text].

  19. Kosmidou I, Redfors B, Dordi R, et al. Incidence, predictors, and outcomes of high-grade atrioventricular block in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention (from the HORIZONS-AMI Trial). Am J Cardiol. 2017 May 1. 119(9):1295-301. [QxMD MEDLINE Link].

  20. Kojic EM, Hardarson T, Sigfusson N, Sigvaldason H. The prevalence and prognosis of third-degree atrioventricular conduction block: the Reykjavik study. J Intern Med. 1999 Jul. 246(1):81-6. [QxMD MEDLINE Link]. [Full Text].

  21. Hayashi T, Ono H, Kaneko Y. Echocardiographic assessment of ventricular contraction and synchrony in children with isolated complete atrioventricular block and epicardial pacing: Implications of interventricular mechanical delay. Echocardiography. 2018 Sep. 35(9):1370-7. [QxMD MEDLINE Link].

  22. Takaoka H, Funabashi N, Ozawa K, et al. Computed tomography is important in appropriately diagnosing patients with third-degree atrioventricular block and second-degree atrioventricular block but not Wenckebach type. Int J Cardiol. 2017 Feb 1. 228:700-6. [QxMD MEDLINE Link].

  23. Zhao Q, Wo JS, Guo J, Cai SL. Evaluation of cardiac function by pacing at different right ventricular sites in patients with third-degree atrioventricular block using Doppler ultrasound. Int J Clin Exp Med. 2015. 8(5):6822-8. [QxMD MEDLINE Link]. [Full Text].

  24. [Guideline] Epstein AE, Dimarco JP, Ellenbogen KA, et al, for the American College of Cardiology/American Heart Association Task Force on Practice, American Association for Thoracic Surgery, et al. ACC/AHA/HRS 2008 guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: executive summary. Heart Rhythm. 2008 Jun. 5(6):934-55. [QxMD MEDLINE Link].

  25. [Guideline] Tracy CM, Epstein AE, Darbar D, et al. 2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2012 Oct 2. 60(14):1297-313. [QxMD MEDLINE Link]. [Full Text].

  26. [Guideline] Emergency Cardiac Care Committee and Subcommittees, American Heart Association. Guidelines for cardiopulmonary resuscitation and emergency cardiac care. Part III. Adult advanced cardiac life support. JAMA. 1992 Oct 28. 268(16):2199-241. [QxMD MEDLINE Link].

  27. [Guideline] International Liaison Committee on Resuscitation. 2005 International consensus on cardiopulmonary resuscitation and emergency cardiovascular care science with treatment recommendations. Part 4: Advanced life support. Resuscitation. 2005 Nov-Dec. 67(2-3):213-47. [QxMD MEDLINE Link].

  28. Syverud S. Cardiac pacing. Emerg Med Clin North Am. 1988 May. 6 (2):197-215. [QxMD MEDLINE Link].

  29. Kim HL, Kim SH, Seo JB, et al, for the Other Korea Acute Myocardial Infarction Registry, Korea Working Group on Myocardial Infarction Investigators. Influence of second- and third-degree heart block on 30-day outcome following acute myocardial infarction in the drug-eluting stent era. Am J Cardiol. 2014 Dec 1. 114(11):1658-62. [QxMD MEDLINE Link].

Author

Coauthor(s)

Daniel Brito Guzman, MD Assistant Professor of Non-Invasive Cardiology, Department of Cardiovascular and Thoracic Surgery, WVU Heart and Vascular Institute

Daniel Brito Guzman, MD is a member of the following medical societies: American College of Physicians, American Thoracic Society

Disclosure: Nothing to disclose.

Specialty Editor Board

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Brian Olshansky, MD, FESC, FAHA, FACC, FHRS Professor Emeritus of Medicine, Department of Internal Medicine, University of Iowa College of Medicine

Brian Olshansky, MD, FESC, FAHA, FACC, FHRS is a member of the following medical societies: American College of Cardiology, American Heart Association, Cardiac Electrophysiology Society, European Society of Cardiology, Heart Rhythm Society

Disclosure: Serve(d) as a director, officer, partner, employee, advisor, consultant or trustee for: Astra Zeneca, Artivion<br/>DSMB.

Chief Editor

Jeffrey N Rottman, MD Professor of Medicine, Department of Medicine, Division of Cardiovascular Medicine, University of Maryland School of Medicine; Cardiologist/Electrophysiologist, University of Maryland Medical System and VA Maryland Health Care System

Jeffrey N Rottman, MD is a member of the following medical societies: American Heart Association, Heart Rhythm Society

Disclosure: Nothing to disclose.

Additional Contributors

Eddy S Lang, MDCM, CCFP(EM), CSPQ Associate Professor, Senior Researcher, Division of Emergency Medicine, Department of Family Medicine, University of Calgary Faculty of Medicine; Assistant Professor, Department of Family Medicine, McGill University Faculty of Medicine, Canada

Eddy S Lang, MDCM, CCFP(EM), CSPQ is a member of the following medical societies: American College of Emergency Physicians, Society for Academic Emergency Medicine, Canadian Association of Emergency Physicians

Disclosure: Nothing to disclose.

Theodore J Gaeta, DO, MPH, FACEP Clinical Associate Professor, Department of Emergency Medicine, Weill Cornell Medical College; Vice Chairman and Program Director of Emergency Medicine Residency Program, Department of Emergency Medicine, New York Methodist Hospital; Academic Chair, Adjunct Professor, Department of Emergency Medicine, St George's University School of Medicine

Theodore J Gaeta, DO, MPH, FACEP is a member of the following medical societies: American College of Emergency Physicians, New York Academy of Medicine, Society for Academic Emergency Medicine, Council of Residency Directors in Emergency Medicine, Clerkship Directors in Emergency Medicine, Alliance for Clinical Education

Disclosure: Nothing to disclose.

James P Daubert, MD Professor of Medicine, Cardiology Division, Duke University School of Medicine

James P Daubert, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Cardiology, American Heart Association, Heart Rhythm Society

Disclosure: Partner received equity interest from Medtronic for none; Received honoraria from Boston Scientific for speaking and teaching; Received consulting fee from CV Therapeutics for consulting; Received consulting fee from Cryocor for consulting.

Andrew C Corsello, MD Consulting Staff, Department of Internal Medicine, Division of Cardiology, Cardiovascular Consultants of Maine, PA

Disclosure: Nothing to disclose.

Adam S Budzikowski, MD, PhD, FHRS Assistant Professor of Medicine, Division of Cardiovascular Medicine, Electrophysiology Section, State University of New York Downstate Medical Center, University Hospital of Brooklyn

Adam S Budzikowski, MD, PhD, FHRS is a member of the following medical societies: European Society of Cardiology, Heart Rhythm Society

Disclosure: Received consulting fee from Boston Scientific for speaking and teaching; Received honoraria from St. Jude Medical for speaking and teaching; Received honoraria from Zoll for speaking and teaching.

Michael D Levine, MD Assistant Professor, Department of Emergency Medicine, Section of Medical Toxicology, Keck School of Medicine of the University of Southern California

Michael D Levine, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Emergency Physicians, American College of Medical Toxicology, American Medical Association, Phi Beta Kappa, Society for Academic Emergency Medicine, Emergency Medicine Residents' Association

Disclosure: Nothing to disclose.

Abrar H Shah, MD Clinical Assistant Professor, Department of Medicine, University of Rochester Medical Center; Consulting Staff, Department of Medicine (Cardiology), Strong Memorial Hospital, Geneva General Hospital; Consulting Staff, Department of Cardiology, Highland Hospital; Consulting Staff, Department of Cardiology and Electrophysiology, Park Ridge Hospital

Disclosure: Nothing to disclose.

How would you describe a complete heart block?

Complete heart block occurs when the electrical signal can't pass normally from the atria, the heart's upper chambers, to the ventricles, or lower chambers. If the atrioventricular (AV) node is damaged during surgery, complete heart block may result. Sometimes complete heart block occurs spontaneously without surgery.

What treatment may help a patient with a complete AV block?

Transcutaneous pacing is the treatment of choice for any symptomatic patient. All patients who have third-degree atrioventricular (AV) block (complete heart block) associated with repeated pauses, an inadequate escape rhythm, or a block below the AV node (AVN) should be stabilized with temporary pacing.

What causes a complete heart block?

Coronary artery disease with and without a heart attack is one of the most common causes of heart block. Cardiomyopathies which are diseases that weaken the heart muscle can also result in wire damage.

Which coronary artery is affected in complete heart block?

CHB is most commonly associated with an occlusion of the right coronary artery (RCA) [3]. The mortality rate of MI is higher if complete heart block is present [1-3]. Thus, prompt recognition of CHB in myocardial infarctions is essential to prevent further deterioration.